Home › Marginal Zone Lymphoma › Florida › Tampa
Marginal Zone Lymphoma clinical trials in Tampa, FL
4 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Tampa General Hospital Cancer Institute, Tampa
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
RecruitingPhase 2
- Moffitt Cancer Center, Tampa
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
RecruitingPhase 1
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Tampa
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY11 studies
- Baldwin Park, CA9 studies
- Seattle, WA9 studies
- Boston, MA9 studies
- Milwaukee, WI9 studies
- Columbus, OH8 studies
- Rochester, MN8 studies
- Edison, NJ8 studies
- Houston, TX8 studies
- Denver, CO7 studies
- Miami, FL7 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer51 studies
- Breast Cancer43 studies
- Cancer (all types)39 studies
- Colorectal Cancer33 studies
- Lung Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Metastatic Cancer29 studies
- Pancreatic Cancer27 studies
- Ovarian Cancer20 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Myelodysplastic Syndromes19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.